https://doi.org/10.4081/mm.2006.3113
VALUTAZIONE DELLE MUTAZIONI DI RESISTENZA AGLI ANTIVIRALI NEI SOGGETTI IN TRATTAMENTO PER INFEZIONE CRONICA DA HBV: MUTAZIONI SECONDARIE INDOTTE DA LAMIVUDINA POSSONO INFLUIRE SUI SUCCESSIVI TRATTAMENTI
Submitted: 26 February 2014
Accepted: 26 February 2014
Published: 30 September 2006
Accepted: 26 February 2014
Abstract Views: 1098
PDF: 393
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Crobu, M., Ravanini, P., Nicosia, A., Grossini, E., Cagliano, M., Kroumova, V., Di Natale, C., & Fortina, G. (2006). VALUTAZIONE DELLE MUTAZIONI DI RESISTENZA AGLI ANTIVIRALI NEI SOGGETTI IN TRATTAMENTO PER INFEZIONE CRONICA DA HBV: MUTAZIONI SECONDARIE INDOTTE DA LAMIVUDINA POSSONO INFLUIRE SUI SUCCESSIVI TRATTAMENTI. Microbiologia Medica, 21(3). https://doi.org/10.4081/mm.2006.3113
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.